Literature DB >> 12062477

Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO.

L-M Kow1, K G Commons, S Ogawa, D W Pfaff.   

Abstract

Several lines of evidence have suggested that mu-opioids, generally regarded as inhibitory, also have effects that stimulate neural activity. To look for possible excitatory opioid action in the rat periaqueductal gray (PAG), we first re-examined data from a previous study and found that met-enkephalin could evoke a delayed, sluggish excitation, suggestive of modulation by the opioid on the action of certain excitants. This observation, coupled with other studies that show mu-opioids can modulate NMDA receptor activation, prompted us to perform extracellular recording of the responses of single ventrolateral PAG (vlPAG) neurons in brain slices to DAMGO, a mu-opioid, and to NMDA. When applied alone, DAMGO at nM concentrations, like met-enkephalin, often evoked the delayed excitation and occasionally an inhibition. When applied after a brief exposure to NMDA, DAMGO at doses as low as 0.1 nM potentiated the excitation produced by a subsequent pulse of NMDA. This occurred, depending on cell type, in 23-100% of vlPAG neurons. The potentiating action of DAMGO was blocked by naloxone, suggesting it was mediated by mu-opioid receptors. Characterization of these mu-opioid actions revealed that the potentiation and the delayed excitation, unlike the inhibition, was not blocked by another opioid antagonist, nalmefene, nor by an inhibitor of the G protein of the G(i) class, N-ethylmaleimide. Moreover, the potentiating action was distinct from the inhibition in that it was: (a) enhanced by repeated opioid applications, (b) exhibited low effective doses, (c) had a long time course (minutes to develop and last tens of minutes) and (d) was present in distinct though overlapping cell populations. These data reveal an unconventional action of opioids in PAG neurons, that is, a potentiation of excitation produced by NMDA. This effect appeared mechanistically distinct from opioid inhibition or disinhibition and may be related to established examples of direct opioid excitation. These observations may help understanding behaviorally important mechanisms linked to acute and chronic opioid functions in the vlPAG.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062477     DOI: 10.1016/s0006-8993(02)02532-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Ana Vicente-Sánchez; Esther Berrocoso; Javier Garzón
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

2.  Influence of intramuscular heat stimulation on modulation of nociception: complex role of central opioid receptors in descending facilitation and inhibition.

Authors:  Hao-Jun You; Jing Lei; Gang Ye; Xiao-Li Fan; Qiang Li
Journal:  J Physiol       Date:  2014-07-18       Impact factor: 5.182

3.  Endometriosis Is Associated With a Shift in MU Opioid and NMDA Receptor Expression in the Brain Periaqueductal Gray.

Authors:  Annelyn Torres-Reverón; Karylane Palermo; Anixa Hernández-López; Siomara Hernández; Myrella L Cruz; Kenira J Thompson; Idhaliz Flores; Caroline B Appleyard
Journal:  Reprod Sci       Date:  2016-04-18       Impact factor: 3.060

4.  The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Ana Vicente-Sánchez; Concha Bailón; Beatriz Martín-Aznar; Javier Garzón
Journal:  Cell Mol Life Sci       Date:  2010-12-14       Impact factor: 9.261

5.  Distribution of methionine and leucine enkephalin neurons within the social behavior circuitry of the male Syrian hamster brain.

Authors:  Avril Genene Holt; Sarah Winans Newman
Journal:  Brain Res       Date:  2004-12-24       Impact factor: 3.252

6.  Supraspinal Gbetagamma-dependent stimulation of PLCbeta originating from G inhibitory protein-mu opioid receptor-coupling is necessary for morphine induced acute hyperalgesia.

Authors:  Enrica Bianchi; Monica Norcini; Alan Smrcka; Carla Ghelardini
Journal:  J Neurochem       Date:  2009-07-27       Impact factor: 5.372

7.  Memantine and dizocilpine interactions with antinociceptive or discriminative stimulus effects of morphine in rats after acute or chronic treatment with morphine.

Authors:  Yukun Chen; Marianne Evola; Alice M Young
Journal:  Psychopharmacology (Berl)       Date:  2012-08-04       Impact factor: 4.530

8.  Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents.

Authors:  Matthew E Klein; Joshua Chandra; Salma Sheriff; Roberto Malinow
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-15       Impact factor: 11.205

9.  Computational modeling of opioid-induced synaptic plasticity in hippocampus.

Authors:  Mehdi Borjkhani; Fariba Bahrami; Mahyar Janahmadi
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

10.  Formation of Opioid-Induced Memory and Its Prevention: A Computational Study.

Authors:  Mehdi Borjkhani; Fariba Bahrami; Mahyar Janahmadi
Journal:  Front Comput Neurosci       Date:  2018-08-02       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.